Romania · Delayed Price · Currency is RON Med Life Statistics
Total Valuation
Med Life has a market cap or net worth of RON 5.03 billion. The enterprise value is 6.80 billion.
| Market Cap | 5.03B |
| Enterprise Value | 6.80B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Med Life has 530.82 million shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 530.82M |
| Shares Outstanding | 530.82M |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.77% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 1,100.19 and the forward PE ratio is 47.95.
| PE Ratio | 1,100.19 |
| Forward PE | 47.95 |
| PS Ratio | 1.62 |
| PB Ratio | 10.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 543.50 |
| P/OCF Ratio | 20.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.28, with an EV/FCF ratio of 735.63.
| EV / Earnings | 1,489.11 |
| EV / Sales | 2.19 |
| EV / EBITDA | 15.28 |
| EV / EBIT | 44.59 |
| EV / FCF | 735.63 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 3.77.
| Current Ratio | 0.82 |
| Quick Ratio | 0.58 |
| Debt / Equity | 3.77 |
| Debt / EBITDA | 4.25 |
| Debt / FCF | 204.63 |
| Interest Coverage | 1.72 |
Financial Efficiency
Return on equity (ROE) is -2.06% and return on invested capital (ROIC) is 4.15%.
| Return on Equity (ROE) | -2.06% |
| Return on Assets (ROA) | 3.13% |
| Return on Invested Capital (ROIC) | 4.15% |
| Return on Capital Employed (ROCE) | 6.69% |
| Revenue Per Employee | 484,766 |
| Profits Per Employee | 712 |
| Employee Count | 6,638 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 11.94 |
Taxes
In the past 12 months, Med Life has paid 24.44 million in taxes.
| Income Tax | 24.44M |
| Effective Tax Rate | 174.98% |
Stock Price Statistics
The stock price has increased by +65.56% in the last 52 weeks. The beta is 0.49, so Med Life's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +65.56% |
| 50-Day Moving Average | 8.37 |
| 200-Day Moving Average | 7.20 |
| Relative Strength Index (RSI) | 74.14 |
| Average Volume (20 Days) | 116,845 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Med Life had revenue of RON 3.11 billion and earned 4.57 million in profits. Earnings per share was 0.01.
| Revenue | 3.11B |
| Gross Profit | 1.51B |
| Operating Income | 152.59M |
| Pretax Income | 13.97M |
| Net Income | 4.57M |
| EBITDA | 354.10M |
| EBIT | 152.59M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 185.35 million in cash and 1.89 billion in debt, giving a net cash position of -1.71 billion or -3.22 per share.
| Cash & Cash Equivalents | 185.35M |
| Total Debt | 1.89B |
| Net Cash | -1.71B |
| Net Cash Per Share | -3.22 |
| Equity (Book Value) | 502.03M |
| Book Value Per Share | 0.81 |
| Working Capital | -157.24M |
Cash Flow
In the last 12 months, operating cash flow was 246.26 million and capital expenditures -237.01 million, giving a free cash flow of 9.25 million.
| Operating Cash Flow | 246.26M |
| Capital Expenditures | -237.01M |
| Free Cash Flow | 9.25M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 48.73%, with operating and profit margins of 4.91% and 0.15%.
| Gross Margin | 48.73% |
| Operating Margin | 4.91% |
| Pretax Margin | 0.45% |
| Profit Margin | 0.15% |
| EBITDA Margin | 11.39% |
| EBIT Margin | 4.91% |
| FCF Margin | 0.30% |
Dividends & Yields
Med Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.05% |
| Earnings Yield | 0.09% |
| FCF Yield | 0.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 1, 2023. It was a forward split with a ratio of 4.
| Last Split Date | Sep 1, 2023 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Med Life has an Altman Z-Score of 1.9 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.9 |
| Piotroski F-Score | 6 |